DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 200 filers reported holding DENALI THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 9.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,804,157 | -41.5% | 135,926 | -16.4% | 0.00% | 0.0% |
| Q2 2023 | $4,796,974 | +66.5% | 162,554 | +30.0% | 0.00% | 0.0% |
| Q1 2023 | $2,881,612 | +60.2% | 125,070 | +93.3% | 0.00% | 0.0% |
| Q4 2022 | $1,799,001 | -9.6% | 64,689 | -0.3% | 0.00% | 0.0% |
| Q3 2022 | $1,991,000 | -2.3% | 64,887 | -6.2% | 0.00% | 0.0% |
| Q2 2022 | $2,037,000 | -42.6% | 69,206 | -37.2% | 0.00% | 0.0% |
| Q1 2022 | $3,547,000 | -44.6% | 110,268 | -23.2% | 0.00% | -50.0% |
| Q4 2021 | $6,402,000 | -23.0% | 143,536 | -12.9% | 0.00% | 0.0% |
| Q3 2021 | $8,311,000 | -28.3% | 164,745 | +11.5% | 0.00% | -33.3% |
| Q2 2021 | $11,592,000 | +74.8% | 147,773 | +27.3% | 0.00% | +200.0% |
| Q1 2021 | $6,631,000 | -36.0% | 116,124 | -6.1% | 0.00% | -50.0% |
| Q4 2020 | $10,361,000 | +237.2% | 123,694 | +44.3% | 0.00% | +100.0% |
| Q3 2020 | $3,073,000 | +58.8% | 85,749 | +7.2% | 0.00% | 0.0% |
| Q2 2020 | $1,935,000 | -30.7% | 79,999 | -49.8% | 0.00% | 0.0% |
| Q1 2020 | $2,791,000 | +10.3% | 159,339 | +9.7% | 0.00% | 0.0% |
| Q4 2019 | $2,531,000 | +13.2% | 145,257 | -0.4% | 0.00% | 0.0% |
| Q3 2019 | $2,235,000 | -22.8% | 145,888 | +4.6% | 0.00% | 0.0% |
| Q2 2019 | $2,895,000 | +71.6% | 139,424 | +91.9% | 0.00% | 0.0% |
| Q1 2019 | $1,687,000 | +9.5% | 72,651 | -2.5% | 0.00% | 0.0% |
| Q4 2018 | $1,540,000 | +2.1% | 74,510 | +7.5% | 0.00% | – |
| Q3 2018 | $1,508,000 | +76.8% | 69,330 | +24.0% | 0.00% | – |
| Q2 2018 | $853,000 | -22.2% | 55,920 | +0.5% | 0.00% | – |
| Q1 2018 | $1,096,000 | +76.5% | 55,647 | +40.2% | 0.00% | – |
| Q4 2017 | $621,000 | – | 39,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 19,462,500 | $339,037,000 | 35.95% |
| Euclidean Capital LLC | 323,749 | $27,117,000 | 5.74% |
| Flagship Pioneering Inc. | 2,730,263 | $228,687,000 | 4.16% |
| Casdin Capital, LLC | 1,310,000 | $109,726,000 | 3.25% |
| A.R.T. Advisors, LLC | 6,173 | $517,000 | 2.39% |
| MARK ASSET MANAGEMENT LP | 172,040 | $14,410,000 | 1.73% |
| Temasek Holdings (Private) Ltd | 4,410,457 | $369,420,000 | 1.59% |
| Integral Health Asset Management, LLC | 57,500 | $4,816,000 | 1.43% |
| GILDER GAGNON HOWE & CO LLC | 3,219,843 | $269,694,000 | 1.34% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 19,365 | $1,622,000 | 0.95% |